Loading company…
Riskpilot
← Back to search
Sign in
Get full access
APOTEK SOKNDAL AS
AS
Active
Org 925552216
Gamleveien 12, 4380 Hauge I Dalane
Retail sale of pharmaceutical products · NACE 4773
Est. 2020
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 17,6M
-1% vs 2023
EBITDA margin
-4.4%
-229% vs 2023
Equity ratio
-11.9%
Financial strength
Net profit 2024
NOK -864K
-475% vs 2023
EBITDA — year on year
NOK millions
1M
1M
0M
-1M
-1M
1M
2021
1M
0%
2022
1M
0%
2023
-1M
-200%
2024
Key figures
Annual report 2024
Revenue
NOK 17,6M
-1%
EBITDA
NOK -768K
-229%
Net profit
NOK -864K
-475%
Total assets
NOK 5M
+7%
Equity
NOK -599K
-326%
Employees
5
—
Company information
Legal name
APOTEK SOKNDAL AS
Org number
925552216
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
28. august 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie og drift av apotek.
Contact
Address
Gamleveien 12, 4380 Hauge I Dalane
Phone
+4751477500
Email
apotek1.sokndal@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Sokndal
All Norway companies
Revenue
NOK millions
0M
5M
10M
16M
21M
14M
2021
16M
2022
18M
2023
18M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
-1M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
14 028
15 824
17 812
17 607
Staff expenses
−1 779
−2 296
−3 061
−3 701
EBITDA
644
623
596
−768
Depreciation & amort.
−212
−212
−313
−313
EBIT
432
411
282
−1 081
Net financials
−24
−18
−23
−27
Profit before tax
407
393
259
−1 108
Tax
90
116
29
−244
Net profit
318
277
230
−864
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
4 378
4 223
4 693
5 030
Equity
348
625
265
−599
Long-term debt
1 247
0
459
406
Short-term debt
2 783
3 598
3 969
5 224
Total debt
4 030
3 598
4 428
5 629
Financial ratios
5-year trend
EBITDA margin
-4.4%
This company
15.8%
Market median
-128% vs market
2021
2024
Equity ratio
-11.9%
This company
38.2%
Market median
-131% vs market
2021
2024
Return on equity
-86447800.0%
This company
18.4%
Market median
-469825100% vs market
2021
2024
Net profit margin
-4.9%
This company
8.1%
Market median
-160% vs market
2021
2024
Asset turnover
3.50×
This company
1.12×
Market median
+212% vs market
2021
2024
Debt / equity
9.39×
This company
0.62×
Market median
-1415% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-08-19 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
GJ
Goran Jafr
Chief Executive Officer
Chief Executive Officer
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MK
Muhammad Kashif Mumtaz
Chairman
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Luqman Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Luqman Holding As
APOTEK SOKNDAL AS
(this company)
Board network connections
Board members of APOTEK SOKNDAL AS also hold positions in
0
other companies.
Person
Role here
Other companies
Goran Jafr
Chief Executive Officer
0 companies
Muhammad Kashif Mumtaz
Chairman
0 companies